Aims: We sought to determine if some unclassified renal cell carcinomas (RCCs) in children and young adults that are characterised by predominantly eosinophilic cytoplasm are related to the recently described succinate dehydrogenase (SDH)-deficient RCC, fumarate hydratase (FH)-deficient RCC or eosinophilic solid and cystic (ESC) RCC. Methods and results: We reviewed 33 unclassified RCCs with predominantly eosinophilic cytoplasm in patients aged 35 years or younger. Immunohistochemistry (IHC) for SDHB, FH and CK20 (a marker of ESC) was performed in all cases. IHC for 2-succinocysteine (2SC) was performed on RCC with loss of FH labelling. Four RCC (12%) (median age 18 years) demonstrated loss of FH labelling as well as aberrant 2SC labelling, and were thus classified as FH-deficient RCCs. Importantly, none of these cases demonstrated the characteristic macronucleoli typical of FH-deficient RCC. Eight RCC (24%) (median age 20.5 years) demonstrated loss of SDHB and were reclassified as SDH-deficient RCCs. Importantly, only four of eight SDH-deficient RCC demonstrated the characteristic cytoplasmic vacuoles and inclusions of typical SDHdeficient RCC. Ten RCC (30%) (median age 27 years) were reclassified as ESC RCCs. Four of 10 ESC RCC were multifocal (one bilateral), four of 10 ESC RCC occurred in males and one patient presented with liver and lung metastases, all not described previously in ESC. Eleven RCC (33%) remained unclassified. Conclusions: Pathologists should have a low threshold for performing FH, SDHB and CK20 IHC when confronted with unclassified eosinophilic RCC or 'oncocytoma' in young patients.
Introduction
Renal cell carcinomas (RCC) are uncommon in children and adolescents, accounting for fewer than 5% of all paediatric renal neoplasms. [1] [2] [3] [4] Nonetheless, evidence indicates that paediatric RCC are clinically, morphologically and genetically different from adult RCC. 5 Unlike adult RCC, the majority of paediatric RCC fall into the category of microphthalmia transcription factor (MiT) family translocation RCC, which includes the Xp11 translocation RCC and t (6;11) RCC. 6, 7 There are also two subtypes of RCC that occur almost exclusively in young patients with sickle cell trait. Renal medullary carcinoma was described first in 1995 by Davis et al. , and termed the 'seventh sickle cell nephropathy'. 8 More recently, RCC harbouring fusion of the vinculin (VCL) and anaplastic lymphoma kinase (ALK) genes have been reported in the same patient population and described as the 'eighth sickle cell nephropathy'. [9] [10] [11] In addition, RCC have been documented to arise in metanephric adenofibroma, a biphasic neoplasm of childhood combining features of metanephric stromal tumour and metanephric adenoma. 12 RCC has also been described as a second malignancy in children with a history of neuroblastomas (NB), and was considered initially a distinct entity in the 2004 World Health Organisation (WHO) classification of renal tumours. 13 However, the latter are now considered a provisional entity in the 2016 WHO classification, as recent studies demonstrate that these neoplasms represent a heterogeneous group of RCC rather than a single entity, with many representing chemotherapyassociated MiT family translocation RCC. [14] [15] [16] Despite these recent advances, many RCC in children and young adults remain difficult to classify. In particular, a significant percentage of these unclassified RCC in children and young adults have been noted to be characterised by predominantly eosinophilic cytoplasm. 17, 18 During the last few years, three new RCC characterised by eosinophilic cytoplasm have been described. First, succinate dehydrogenase (SDH)-deficient RCC occurs in patients with CarneyStratakis syndrome, which is characterised by germline mutations of one of the SDH subunit genes A, B, C or D. These SDH-deficient RCC demonstrate loss of immunohistochemical labelling for SDH subunit B (SDHB), which reflects the resulting destabilisation of the SDH mitochondrial complex II. SDH-deficient RCC are characterised by cytoplasmic vacuoles and inclusion-like spaces containing eosinophilic fluid or flocculent material. [19] [20] [21] Secondly, fumarate hydratase (FH)-deficient RCC, associated with hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome and inactivating germline mutations in the FH gene, is characterised by prominent macronucleoli with perinucleolar clearing. [22] [23] [24] [25] [26] Immunohistochemically, these neoplasms demonstrate loss of FH expression and aberrantly overexpress 2-succinocysteine (2SC). 26 Thirdly, eosinophilic solid and cystic (ESC) RCC has been reported exclusively in adult female patients and is thought to be the sporadic counterpart to one subtype of tuberous sclerosis complex (TSC)-associated RCC. 27, 28 Histologically, the neoplastic cells contain voluminous eosinophilic cytoplasm with coarse cytoplasmic precipitates, and frequently show at least focal expression of cytokeratin 20. Whether these three entities account for a significant proportion of previously unclassified eosinophilic RCC in young patients is unclear.
In this study, we review 33 unclassified RCC from our files that occurred in children and young adults and had predominantly eosinophilic cytoplasm. We assess the morphological features in combination with immunohistochemical labelling for SDHB, SDHA, FH and CK20, hypothesising that a significant number of these previously unclassified neoplasms might be reclassifiable as SDH-deficient RCC, FH-deficient RCC or ESC RCC.
Material and methods

I N S T I T U T I O N A L R E V I E W B O A R D A P P R O V A L
This study was approved by the Institutional Review Board of the Johns Hopkins Hospital and other participating institutions.
C A S E S
We reviewed 33 cases diagnosed originally as unclassified renal cell carcinomas with eosinophilic cytoplasm in patients younger than 35 years of age. Where to draw an age cut-off to define 'young' is unclear; we chose 35 years of age as our cut-off because it is a full two decades younger than the median age of occurrence of renal cell carcinoma (55 years). Moreover, while our files contained only 13 such cases under the age of 18 years, the cases in the 18-35-year age group were highly similar morphologically. The cases were collected during 2008-17, with one case coming from the institutional files at the Johns Hopkins Hospital and the rest (32 cases) from the consultation files of one of the authors (P.A.). These 32 cases represented 12% of the 261 renal tumour consultations in patients in this age group reviewed by this author (P.A.) in this timeframe. Thirty-one cases were given a final diagnosis of unclassified RCC. Two cases which were reviewed while this study was ongoing were thought to be unclassified based on haematoxylin and eosin (H&E) sections and routine immunohistochemistry, but were reclassified following SDHB and FH immunohistochemistry, which was performed reflexively based on our preliminary study results. Formalin-fixed, paraffin-embedded tissue samples and clinical data were obtained from the submitting clinicians (consultation cases) or from the pathology archives and institutional patient database at the Johns Hopkins Hospital.
I M M U N O H I S T O C H E M I S T R Y
Immunohistochemistry (IHC) was performed on the Benchmark XT autostainer (Ventana Medical Systems Inc., Tucson, AZ, USA) for FH (J-13; Santa Cruz Biotechnology, Santa Cruz, CA, USA; 1:200 dilution) and CK20 (ks20.8; Dako, Carpinteria, CA, USA; pre-diluted). IHC for SDHB (catalogue no. M7195; Abcam, Cambridge, MA, USA; 1:100 dilution) was performed on the Leica Biosystems autostainer. SDHA IHC was performed as described previously. 29 Although there is not yet a commercially available antibody for the detection of 2SC, the generation of a polyclonal antibody for experimental purposes has been described by Nagai et al. 30 IHC for 2SC was performed using this polyclonal antibody and the method described by Bardella et al. 31 Antigen retrieval was performed by microwaving in pH 6.0 citrate buffer for 15 min. The tissues were then blocked for endogenous peroxidase and incubated with 2SC polyclonal antibody (1:5000 dilution). This was followed by washing in phosphate-buffered saline (PBS) (0.1% Tween 20) and incubation with anti-rabbit horseradish peroxidase (HRP) polymer (Envision; Dako) for 30 min. The positive control consisted of an RCC from a genetically confirmed HLRCC patient.
For FH, SDHB and SDHA, a complete absence of labelling of neoplastic cells in the presence of intact labelling of normal tissue was considered loss of expression. For CK20 and 2SC, any labelling of neoplastic cells was considered as a positive result.
Results
C A S E S
All but one of the cases were sent for consultation of renal tumour classification; the one remaining case was reviewed from the in-house surgical pathology archives of the Johns Hopkins Hospital. Of note, a total of 13 cases (nine of 10 ESC RCC and four of eight SDH-deficient RCC) were sent for consultation to rule out MiT family translocation RCC. The number of slides reviewed varied, with a mean of seven slides per case (range: 1-24 slides/case). (Table 1 , Figures 1 and 2 ). The four patients had a median age of 18 years (range: 10-25 years); three patients were female, one was male. Importantly, none of these cases demonstrated papillary architecture or the characteristic macronucleoli typical of FHdeficient RCC in adults; instead, all demonstrated a nested tubular appearance and inconspicuous nucleoli that suggested oncocytoma. Along these lines, one case was submitted with a diagnosis of oncocytoma. Two of four FH-deficient tumours were partially cystic, while one was multifocal. In the surrounding kidney of the latter case, 2SC immunostain highlighted multiple additional small clusters of and single neoplastic cells ( Figure 1G-I ). All four FH-deficient RCC demonstrated intact SDHB labelling, and all were negative for cytokeratin 20. Clinical follow-up was available for one of four patients; she was free of disease at 24 months with no personal or family history of HLRCC.
S D H -D E F I C I E N T R C C
Eight cases (24%) demonstrated loss of SDHB by IHC and were thus reclassified as SDH-deficient RCC ( Table 2 ). All eight SDHB IHC-negative cases demonstrated intact SDHA labelling by IHC. All six SDH-deficient RCC tested demonstrated intact FH labelling, and all five cases tested were negative for cytokeratin 20. The patients had a median age of 20.5 years (range: 17-34 years); six patients were male and two were female. Importantly, these cases demonstrated fewer of the cytoplasmic vacuoles and inclusions that are typical of previously reported adult SDH-deficient RCC. Only four of eight SDHdeficient RCC demonstrated cytoplasmic vacuoles and/or inclusions. Three of eight SDH-deficient RCC were submitted with the differential diagnosis of oncocytoma (one of which had been diagnosed as an oncocytoma on intraoperative frozen section), while two of eight SDH-deficient RCCs mimicked the biphasic morphology of the t(6;11) RCC, in that it showed clusters of small cells surrounding basement membrane material ( Figure 3 ). These two cases had been submitted in consultation to rule out t(6;11) RCC; however, fluorescence in-situ hybridisation (FISH) did not detect a TFEB gene rearrangement, and melanocytic markers were negative. One case demonstrated pleomorphism throughout and extensive necrosis, and presented with bone metastasis. This well-sampled neoplasm (all 13 sections from a 10-cm tumour were reviewed) lacked cytoplasmic inclusions and vacuoles; however, a cytokeratin stain highlighted globular, cytoplasmic inclusions ( Figure 4) . SDHA was diffusely positive in the case but did not highlight the inclusions. Clinical followup was available for two of eight patients. These two patients showed no evidence of disease at 11 and 61 months; neither had a personal or family history of Carney-Stratakis syndrome. E S C R C C Ten cases (30%) were reclassified as ESC RCCs (Table  3) , with a median age of 27 years (range: 14-35 years); six patients were female and four were male. All 10 of these cases were focally immunoreactive for cytokeratin 20, and demonstrated intact FH and SDHB labelling. All 10 neoplasms demonstrated the morphological features described recently by Trpkov et al. 27, 28 solid and cystic architecture, voluminous eosinophilic cytoplasm and flocculent cytoplasmic precipitates and focal CK20 expression ( Figures 5 and 6 ). Four of 10 ESC RCC were multifocal (one bilateral), while two of 10 ESC RCC patients had a history of a prior malignancy [bladder and central nervous system (CNS)]. One patient presented with metastatic disease involving the lung and liver ( Figure 7 ). Clinical follow-up was available for two of 10 patients. These two patients showed no evidence of disease at 4.5 and 72 months; neither had a personal or family history of tuberous sclerosis. Of eight cases tested, five (62.5%) showed focal labelling for cathepsin K by IHC. None of these cases demonstrated evidence of MiT family translocations. Three of five cases were negative for both TFE3 and TFEB rearrangements by FISH, one of five cases was negative for TFE3 rearrangement by FISH and negative for TFEB by IHC, and FISH could not be performed on one case due to technical difficulties.
U N C L A S S I F I E D R C C
Eleven cases (33%) remained unclassified, with a median age of 15 years (range: 29 months-27 years); eight patients were female and three were male. Four of 11 unclassified RCCs showed some features overlapping ESC RCC, including focal CK20 expression, but lacked well-developed cytoplasmic precipitates. The remaining cases demonstrated variable morphology.
Discussion
Paediatric RCC are different from adult RCC in several ways. Most significantly, the majority of paediatric RCC fall into the category of MiT family translocation RCC. Other specific entities that predominate in young patients include renal medullary RCC and VCL-ALK RCC associated with sickle cell trait, along with RCC arising in metanephric adenofibroma. However, a high proportion of paediatric RCC have remained unclassified. We and others have noted previously that many of these unclassified paediatric RCC are characterised by predominantly eosinophilic cytoplasm. 17, 18 In this study, we re-evaluated a cohort of previously unclassified RCC in children and young adults of aged <35 years with predominant eosinophilic cytoplasm using markers for the recently described entities of FH-deficient RCC, SDH-deficient RCC and ESC RCC. We find that the majority of the previously unclassified RCC in young patients can now be reclassified into one of these diagnostic categories. Without knowing, one might suspect that these findings occurred simply because our cases date back to 2008, when these entities were not described, and that these were typical examples of these subsequently described entities. However, this was not the case: our findings in young patients expand the clinical and morphological spectrum described previously for these RCC entities.
FH-deficient RCC is associated with HLRCC syndrome, an autosomal dominant disorder characterised 36 These have been referred to as FH-deficient RCC, and some are thought to harbour somatic (not germline) alterations in the Fumarate hydratase gene. 36, 37 Although our four cases of FH-deficient RCC showed loss of FH expression with concomitant 2SC overexpression, they lacked the classic prominent nucleoli typical of previously described FH-deficient RCC. Instead, the neoplasms resembled oncocytomas, which is probably the reason that they were not initially evaluated for FH expression and thus were originally considered unclassified. To our knowledge, this unusual morphology has been described in only one case report of a FH-deficient RCC in a paediatric patient with HLRCC, 38 as well as recently in a small subset of adult FH-deficient RCC cases. 39 Chen et al.
noted that macronucleoli are not present uniformly throughout HLRCC cases, but did not describe oncocytoma-like areas and noted that large nucleoli were seen typically in scattered cells. 26 It is unclear as to whether the FH-deficient RCC in our study are HLRCC-associated or sporadic, as germline DNA testing was beyond the scope of this consultation-based study. There were no findings suggestive of syndromic features in the limited clinical follow-up, although the multifocal presentation of FH-deficient case 1 is highly suspicious for a hereditary predisposition, especially given that HLRCC penetrance is variable. 32, 34 Nonetheless, our findings support the routine use of FH IHC in oncocytoma-like or unclassified eosinophilic renal neoplasms in young patients, along with close follow-up and genetic testing, given the aggressive nature of HLRCC-associated RCC.
SDH-deficient RCC occurs in patients with germline mutations in one of the SDH subunit genes SDHA, SDHB, SDHC or SDHD, although SDHB mutation is most common. Loss of immunohistochemical labelling for SDHB in SDH-deficient RCC reflects the resulting destabilisation of the SDH complex. Histologically, the most distinctive feature is the presence of cytoplasmic vacuoles and inclusion-like spaces containing eosinophilic fluid or flocculent material. The eight cases reclassified as SDH-deficient RCC in our study demonstrated minimal vacuoles and/or inclusions, which is why these cases were not tested initially for SDHB by IHC. The intact SDHA IHC indicates that this gene is probably intact in these cases, and that the mutations or other genetic alterations (such as the methylation of SDHC seen in Carney's triad) probably affect SDHB, SDHC or SDHD. Two of our SDH-deficient cases exhibited oncocytoma-like features, although with higher cellularity and less oedematous stroma. Two cases mimicked the t(6;11) RCC, as they demonstrated biphasic morphology and clusters of small cells surrounded by basement membrane material. One case showed prominent pleomorphism with no identifiable vacuoles or inclusions and H&E sections; however, the dot-like cytokeratin IHC labelling suggested incipient, inclusion-like cytoplasmic filament condensation, although SHDA IHC labelling did not highlight these inclusions. The significance of this pattern is not clear. In the largest study published to date, all 17 SDH-deficient RCC patients who underwent genetic testing demonstrated germline mutations in the SDHB subunit. 19 Although somatic SDH loss is not well described, syndromic manifestations of SDH deficiency have variable penetrance. Clinically, for example, a significant subset of SDH-deficient syndromic paragangliomas (7-24%) mimics sporadic paraganglioma. 40 As such, the absence of a family history does not exclude the presence of a hereditary syndrome. Therefore, while there were no findings suggestive of Carney-Stratakis syndrome in our cases, caution is warranted as clinical follow-up is limited. Nonetheless, our results support the routine use of SDHB IHC in evaluating unclassified eosinophilic RCC, including oncocytoma-like lesions, in young patients as well as clinical follow-up for stigmata of Carney-Stratakis syndrome.
ESC RCC was described recently by Trpkov et al. as a novel and indolent lesion occurring exclusively in adult females. It is thought to be the sporadic counterpart to one subtype of tuberous sclerosis complex (TSC)-associated RCC. 41, 42 Histologically, the neoplastic cells contain voluminous eosinophilic cytoplasm with flocculent cytoplasmic precipitates. Immunohistochemistry usually reveals at least focal expression of 28 Finally, five of the cases demonstrated focal labelling for cathepsin K, typically a marker of MiT family translocation RCC and perivascular epithelioid cell tumours (PEComas). The latter is intriguing, given that ESC is proposed to be a sporadic counterpart to one subtype of tuberous-sclerosis-associated RCC, and the classic TSC-associated neoplasm PEComa expresses cathepsin K consistently. 43, 44 With regard to the cases that remained unclassified following our review, some demonstrated ESC-like morphology but lacked other important features, mainly cytoplasmic precipitates, despite focal CK20 expression. We excluded these cases, but it is possible that they are related to the ESC RCC. Similarly, given the lack of proven specificity of CK20 labelling and the somewhat subjective nature of the morphological criteria for ESC, it is possible that some of our cases (and those in the original descriptions) are not true ESC. Such diagnostic challenges highlight the need for more specific genetic markers of this proposed tumour type.
In summary, we report that renal neoplasms with FH or SDHB loss in young patients often lack the previously described typical morphological features, and often mimic oncocytoma. In addition, we find that ESC RCC occur in children, can affect males, are often multifocal and can metastasise. Thus, pathologists should have a low threshold for performing FH, SDHB and CK20 IHC when confronted with unclassified eosinophilic RCC or oncocytoma-like lesions in young patients. Indeed, it is now our practice to perform such IHC stains (especially FH and SHDB) when evaluating otherwise unclassifiable eosinophilic RCC in patients of any age. We think that loss of FH or SDHB in an otherwise unclassifiable RCC establishes a working diagnosis. Whether any of these cases (particularly the FH and SDH-deficient RCC) reflect germline alterations remains unclear. We did not have adequate material to address this possibility directly: there was typically only minimal normal tissue present in the blocks or unstained slides available to us, and peripheral blood was not available. Moreover, not all alterations (such as FH deletions) may be detected by many sequencing techniques. While we found no clinical evidence for a hereditary syndrome in any of our cases, our clinical follow-up was extremely limited despite maximal efforts. We attempted to contact the patients' treating physicians from these consultation cases directly (some from almost 10 years ago), but this met with little success. Hence, our findings do not exclude the possibility of familial implications. At this time, we suggest that young patients whose RCC show FH or SDH deficiency, like their adult counterparts, undergo indepth clinical assessment to evaluate for a hereditary syndrome and be offered the possibility of germline FH and SDH gene mutation analysis. 
